Secretario de Salud de EE.UU. suspende la aplicación contra seis péptidos no aprobados

Secretario de Salud de EE.UU. suspende la aplicación contra seis péptidos no aprobados

El secretario de Salud de EE. UU. , Robert F. Kennedy Jr. , anunció el 28 de octubre en Washington, D.

C. , que el Departamento de Salud y Servicios Humanos dejará de aplicar sanciones contra la venta de seis compuestos peptídicos preparados, a pesar de las advertencias de seguridad de la FDA. El anuncio se produce después de que el mismo departamento otorgara una discreción temporal de aplicación a principios de la semana, indicando que no se emprenderán acciones legales contra las farmacias que preparen los seis péptidos mientras se espera un cambio formal de normativa. La mayoría del personal científico de la FDA había manifestado previamente su oposición al plan, citando preocupaciones sobre la seguridad de los compuestos.

Actores

U.S. Department of Health and Human Services Emily Hilliard Dr. Peter Lurie Shabbir Safdar Medivant Healthcare

Ubicaciones

Washington, D.C., United States

Artículos

29 de octubre de 2026
1 en total
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them

The Independent • 29 de oct 00:39

Robert F. Kennedy Jr. announced a policy that will stop enforcement against the sale of six compounded peptide compounds, despite FDA warnings about their safety.

Credibilidad 68% Manip. 12% Centro
28 de octubre de 2026
4 en total
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides

NPR • 28 de oct 22:26

The Department of Health and Human Services announced a policy allowing 503A compounding pharmacies to prepare six peptides that have not received FDA approval, sparking debate over safety and supply.

Credibilidad 73% Manip. 10% Centro
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA

Ars Technica • 28 de oct 22:17

Robert F. Kennedy, the U.S. Health Secretary, announced a policy that stops HHS from enforcing against compounding pharmacies that produce six specific peptide substances, despite FDA scientists’ safety concerns.

Credibilidad 55% Manip. 45% Izquierda
FDA scientists opposed Trump administration’s move to ease peptide access
FDA scientists opposed Trump administration’s move to ease peptide access

The Guardian • 28 de oct 18:35

Most FDA scientific staff opposed a Health and Human Services proposal that would limit enforcement against specialty pharmacies selling unapproved peptide drugs, citing safety concerns.

Credibilidad 68% Manip. 25% Centro
RFK Jr. takes shortcut to make some peptides more widely available
RFK Jr. takes shortcut to make some peptides more widely available

NBC News • 28 de oct 16:13

The Department of Health and Human Services will not pursue legal action against compounding pharmacies that produce six specific peptides while a formal rule change is pending.

Credibilidad 78% Manip. 30% Centro